EMILY FUSON: Open Payments
NPI 1881332047 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$593 in 33 payments from 16 companies in 2025. Trend: 2023 $1,100 · 2024 $1,030 · 2025 $593
Food & beverage: $593
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $143 |
| Sumitomo Pharma America, Inc. | 5 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Lundbeck LLC | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $21 |
| Ardelyx, Inc. | 1 | $20 |
Products named: REXULTI, VRAYLAR, GEMTESA, XIFAXAN, GVOKE HYPOPEN, QULIPTA, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
